Nonprofit · EIN 38-1613280
BARBARA ANN KARMANOS CANCER INSTITUTE
Tax-exempt · DETROIT, MI 48201
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| September 30, 2025 | 990 | $27,111,385 | $33,992,462 | -$6,881,077 | $295,118,020 | $30,702,997 | $264,415,023 |
| September 30, 2024 | 990 | $25,395,959 | $32,770,709 | -$7,374,750 | $250,659,734 | $38,743,257 | $211,916,477 |
| September 30, 2023 | 990 (amended) | $24,422,883 | $32,095,526 | -$7,672,643 | $262,170,775 | $34,292,057 | $227,878,718 |
Financial details: 990 for the year ended September 30, 2025
Revenue
- Contributions, gifts and grants
- $8,417,788
- Program service revenue
- $11,852,220
- Investment income
- $6,870,236
- Net gain from sales of assets
- $2,594,726
- Net income from fundraising events
- -$28,859
- Other revenue
- -$28,859
Expenses
- Grants and similar amounts paid
- $87,906
- Compensation of officers, directors and key employees
- $2,455,298
- Other salaries and wages
- $10,462,479
- Salaries, compensation and benefits (total)
- $14,566,608
- Professional fundraising fees
- $0
- Legal fees
- $119,214
- Accounting fees
- $50,920
- Occupancy
- $838,762
- Travel
- $202,111
- Depreciation
- $306,275
- Program services (functional)
- $27,100,455
- Management and general (functional)
- $5,085,141
- Fundraising (functional)
- $1,806,866
Balance sheet and other
- Total assets, start of year
- $250,659,734
- Total assets, end of year
- $295,118,020
- Total liabilities, end of year
- $30,702,997
- Net assets, end of year
- $264,415,023
- Land, buildings and equipment
- $1,667,008
- Publicly traded securities
- $129,350,268
- Net assets without donor restrictions
- $215,976,112
- Net assets with donor restrictions
- $48,438,911
- Gross receipts
- $153,587,723
- Employees
- 313
- Volunteers
- 12
- Year formed
- 1947
- State of legal domicile
- MI
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended September 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| PHILIP A INCARNATI | BOARD MEMBER Trustee or director | 1 | $0 | $12,956,846 | $79,753 |
| BORIS PASCHE | BOARD MEMBER/PRESIDENT KCI Trustee or director, Officer | 21 | $0 | $735,782 | $18,785 |
| REGINA DOXTADER | VP CHIEF FINANCIAL OFFICER Officer | 20 | $427,422 | $0 | $41,684 |
| ARNOLD D'AMBROSIO | CHIEF DEVELOPMENT OFFICER Key employee | 40 | $343,824 | $0 | $36,852 |
| AMY HEIDT RYDER | VP HUMAN RESOURCES Key employee | 40 | $311,062 | $0 | $37,911 |
| SCOTT F MCCARTER | IT SITE DELIVERY MANAGER Key employee | 40 | $246,262 | $0 | $50,609 |
| EVANO PIASENTIN | VP ACD RESEARCH ADMIN - PART YEAR Key employee | 40 | $273,633 | $0 | $13,696 |
| DORIS F RANSKI-ZAZULA | VP KARMANOS CANCER NETWORK Key employee | 40 | $247,980 | $0 | $21,588 |
| JOSEPH E NUGENT | DIRECTOR INFORMATION TECHNOLOGY SVC Key employee | 40 | $220,982 | $0 | $25,029 |
| JODY S HURTUBISE | DIRECTOR ACCOUNTING FINANCE Key employee | 40 | $202,058 | $0 | $29,871 |
| TAMARA M COLLINS | VP MARKETING BUSINESS DEVELOPMENT Key employee | 40 | $208,191 | $0 | $9,676 |
| MONICA L PAPASIAN | DIRECTOR ACCOUNTING FINANCE - PART YEAR Key employee | 40 | $183,477 | $0 | $28,780 |
| RICHARD B MORRISON | SYSTEMS ENGINEER SR Highest-paid employee | 40 | $153,445 | $0 | $47,848 |
| BENJAMIN L HERRING | VP ACD RESEARCH ADMINISTRATION Highest-paid employee | 40 | $161,893 | $0 | $37,209 |
| AMY L POLK | REGIONAL DIRECTOR OF CANCER SERVICES Key employee | 40 | $158,337 | $0 | $37,031 |
18 more people on this return
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| THOMAS E BELCHER | MANAGER IT PROGRAMS Highest-paid employee | 40 | $169,823 | $0 | $23,253 |
| PATRICIA A KEIGHER | REGIONAL DIRECTOR OF CANCER SERVICES Key employee | 40 | $174,069 | $0 | $14,918 |
| TAMARA HIGHTOWER | REGIONAL DIRECTOR OF CANCER SERVICES Highest-paid employee | 40 | $155,378 | $0 | $26,009 |
| NANCY KING | REGIONAL DIRECTOR OF CANCER SERVICES Highest-paid employee | 40 | $151,003 | $0 | $26,314 |
| ANN SCHWARTZ | VP RESEARCH ACADEMIC & AFFAIRS/DEPT DIRECTOR Key employee | 40 | $162,086 | $0 | $3,256 |
| TIMONTHY MONAHAN | BOARD MEMBER & CHAIR Trustee or director, Officer | 1 | $0 | $39,500 | $0 |
| DANIEL RET | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| DAVID E DUPREY | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| DEBORAH SAVOIE | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| DEBRA PARTRICH | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| GEANEEN M ARENDS | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| KELLY LAFONTAINE | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| KIMBERLY ESPY | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| MICHAEL DUHAIME | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SCOTT HUNTER | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SHARI FERBER-KAUFMAN | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SYLVESTER HESTER | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| TOM KALAS | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
990 for the year ended September 30, 2024: 33 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| PHILIP A INCARNATI | BOARD MEMBER Trustee or director | 1 | $0 | $11,811,455 | $48,318 |
| GEROLD BEPLER MD PHD | FORMER PRESIDENT & CEO, SECRETARY Former | 1 | $0 | $1,134,476 | $0 |
| PRAVEEN DALMIA | CORP DIR RADIATION SVCS-PART YEAR Key employee | 40 | $437,987 | $0 | $50,364 |
| SCOTT MCCARTER | IT SITE DELIVERY MANAGER Key employee | 40 | $318,340 | $0 | $58,843 |
| REGINA DOXTADER | VP CFO & SECRETARY Officer | 21 | $339,822 | $0 | $23,984 |
| LAUREN LAWRENCE | VP KARMANOS CANCER NETWORK-PART YEAR Key employee | 40 | $315,135 | $0 | $20,962 |
| AMY RYDER | VP HUMAN RESOURCES Key employee | 40 | $297,459 | $0 | $34,559 |
| EVANO PIASENTIN | ACD & VP RESEARCH ADMIN Key employee | 40 | $278,442 | $0 | $13,169 |
| BORIS PASCHE MD | BOARD MEMBER/PRESIDENT KCI Trustee or director, Officer | 41 | $0 | $246,785 | $2,048 |
| DORIS RANSKI-ZAZULA | VP KARMANOS CANCER NETWORK Key employee | 40 | $222,277 | $0 | $19,585 |
| JOSEPH NUGENT | DIRECTOR INFORMATION TECHNOLOGY SVC Key employee | 40 | $206,988 | $0 | $23,187 |
| MONICA PAPASIAN | DIRECTOR OF FINANCE ACCOUNTING Key employee | 40 | $188,219 | $0 | $26,274 |
| ANN SCHWARTZ | VP RES & ADAC AFFAIRS/DEP DIRECTOR Key employee | 40 | $206,867 | $0 | $4,151 |
| RICHARD MORRISON | SYSTEMS ENGINEER SR Highest-paid employee | 40 | $171,110 | $0 | $32,549 |
| BENJAMIN HERRING | DIR RESEARCH ADMINISTRATION Highest-paid employee | 40 | $159,154 | $0 | $34,165 |
| NICHOLAS ERIKSON | REG DIR CANCER SERVICES - PART YEAR Highest-paid employee | 40 | $157,940 | $0 | $35,239 |
| SARAH BIGELOW | VP CLINICAL TRIALS OFFICE Key employee | 40 | $184,449 | $0 | $6,954 |
| PATRICIA KEIGHER | REG DIR CANCER SERVICES Key employee | 40 | $176,755 | $0 | $14,291 |
| TAMARA COLLINS | VP MARKETING BUSINESS DEV Key employee | 40 | $172,717 | $0 | $12,212 |
| THOMAS BELCHER | MGR IT PROGRAMS Highest-paid employee | 40 | $159,416 | $0 | $19,755 |
| JODY HURTUBISE | DIR ACCOUNTING FINANCE Highest-paid employee | 40 | $149,915 | $0 | $15,585 |
| TIMONTHY MONAHAN | BOARD MEMBER & CHAIR Trustee or director | 1 | $0 | $36,000 | $0 |
| DANIEL RET | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| KIMBERLY ESPY PHD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| GEANEEN M ARENDS | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| KAREN CULLEN | BOARD MEMBER - PART YEAR Trustee or director | 1 | $0 | $0 | $0 |
| MICHAEL DUHAIME | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| DAVID E DUPREY | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SHARI FERBER-KAUFMAN | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SYLVESTER HESTER | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| JIM BENNETHUM | BOARD MEMBER - PART YEAR Trustee or director | 1 | $0 | $0 | $0 |
| SCOTT HUNTER | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| TOM KALAS | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
990 for the year ended September 30, 2023: 30 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| PHILIP A INCARNATI | BOARD MEMBER Trustee or director | 1 | $0 | $10,748,363 | $35,341 |
| GEROLD BEPLER MD PH D | FORMER PRESIDENT & CEO; SECRETARY Former | 1 | $0 | $1,374,928 | $17,482 |
| BRIAN R GAMBLE | CFO, PRESIDENT KCC & CEO Trustee or director, Officer | 44 | $300,865 | $254,013 | $93,035 |
| PRAVEEN DALMIA | CORP DIR FOR RADIATION SVCS Key employee | 45 | $420,259 | $0 | $66,014 |
| SCOTT MCCARTER | VP INFORMATION TECHNOLOGY SVC Key employee | 45 | $291,630 | $0 | $59,473 |
| AMY RYDER | VP HUMAN RESOURCES Key employee | 45 | $280,914 | $0 | $30,609 |
| LAUREN LAWRENCE | VP KARMANOS CANCER NETWORK Key employee | 45 | $283,645 | $0 | $20,360 |
| EVANO PIASENTIN | ACD & VP RESEARCH ADMIN Key employee | 45 | $233,224 | $0 | $12,025 |
| LISA LANGE | VP CLINICAL TRIALS Key employee | 45 | $216,794 | $0 | $25,102 |
| DORIS RANSKI-ZAZULA | REGIONAL DIR CANCER SVCS Highest-paid employee | 45 | $201,264 | $0 | $25,141 |
| JOSEPH NUGENT | DIRECTOR INFORMATION TECHNOLOGY SVCS Highest-paid employee | 45 | $195,602 | $0 | $21,665 |
| NICHOLAS ERIKSON | REGIONAL DIR CANCER SVCS Highest-paid employee | 45 | $168,026 | $0 | $41,753 |
| MARK BITZ | DIRECTOR INFORMATION TECHNOLOGY SVCS Highest-paid employee | 45 | $180,610 | $0 | $15,312 |
| KATRINA BEZAK | REGIONAL DIR CANCER SVCS Highest-paid employee | 45 | $163,885 | $0 | $22,568 |
| TAMARA COLLINS | VP MARKETING BUSINESS DEV Key employee | 45 | $159,114 | $0 | $19,766 |
| ANN SCHWARTZ | VP RES & ADAC AFFAIRS/DEP DIRECTOR Key employee | 45 | $155,032 | $0 | $3,181 |
| REGINA DOXTADER | VP CFO & SECRETARY Officer | 25 | $18,750 | $0 | $0 |
| TIMONTHY MONAHAN | BOARD MEMBER & CHAIR Trustee or director | 1 | $0 | $16,500 | $0 |
| JOSEPH UBERTI MD | BOARD MEMBER - PART YEAR Trustee or director | 1 | $0 | $0 | $0 |
| GEANEEN M ARENDS | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| KAREN CULLEN | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| DAVID E DUPREY | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SHARI FERBER-KAUFMAN | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| M ROY WILSON MD | BOARD MEMBER - PART YEAR Trustee or director | 1 | $0 | $0 | $0 |
| JIM BENNETHUM | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SCOTT HUNTER | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| TOM KALAS | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SYLVESTER HESTER | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| BORIS PASCHE MD | BOARD MEMBER/ PRESIDENT KCI Trustee or director | 1 | $0 | $0 | $0 |
| KIMBERLY ESPY PHD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 4100 JOHN R ST, DETROIT, MI 48201-2013
- Principal officer (990 for 2024)
- BORIS PASCHE MD, 4100 JOHN R, DETROIT, MI 48201
- Signed the 990
- BORIS PASCHE MD, PRESIDENT
- Phone
- (800) 527-6266
- Website
- WWW.KARMANOS.ORG
- Return prepared by
- PLANTE & MORAN PLLC
Mission
TO LEAD IN TRANSFORMATIVE CANCER CARE, RESEARCH AND EDUCATION, DRIVEN BY COMPASSION, COMMITMENT, AND COURAGE TO CREATE A WORLD FREE OF CANCER.
Program accomplishments
- CANCER RESEARCH: AT KARMANOS CANCER INSTITUTE (KCI), THE INSTITUTE'S INVESTIGATORS CONDUCT ALL FORMS OF RESEARCH INTO THE PREVENTION, DETECTION, TREATMENT AND CAUSES OF CANCER. TYPES OF RESEARCH CONDUCTED AT KCI INCLUDE: BASIC, CLINICAL, EPIDEMIOLOGICAL AND BEHAVIORAL. THE CORE RESEARCH FACILITIES OF KCI SERVE TO ENHANCE RESEARCH IN ALL OF THE PROGRAMS BY SUPPLYING INSTRUMENTATION AND/OR EXPERTISE THAT INDIVIDUAL INVESTIGATORS REQUIRE TO PERFORM CUTTING-EDGE RESEARCH. RESEARCH AT KCI IS ORGANIZED WITHIN THE FOLLOWING THREE PROGRAMS: (1) TUMOR BIOLOGY & MICROENVIRONMENT, (2) MOLECULAR THERAPEUTICS, AND (3) POPULATION STUDIES.Expenses $21,783,526 · revenue $6,985,146
- AFFILIATION/NETWORK SUPPORT, COMMUNITY EDUCATION, CORD STEM CELL BANK : COMMUNITY EDUCATION PROVIDED BY KCI STAFF AND VOLUNTEERS OCCUR THROUGH VISITS TO BUSINESSES, CHURCHES, SCHOOLS, SHOPPING MALLS, HEALTH CARE FORUMS AND VIRTUALLY ANY VENUE CONDUCIVE TO INFORMING INDIVIDUALS ON WAYS TO PREVENT CANCER AND ITS WARNING SIGNS, AND THE VERY LATEST IN SCREENING, DIAGNOSTICS, TREATMENT AND FOLLOW-UP CARE THROUGH EDUCATIONAL PRESENTATIONS, MATERIALS AND DISPLAYS. KCI OFFERS FREE FACT SHEETS ON THE MOST COMMON FORMS OF CANCER AND TOPICS OF INTEREST. THESE ARE GEARED TO PERSONS CONCERNED ABOUT THEIR CANCER RISK AND INTERESTED IN PREVENTION AND EARLY DETECTION, NOT TO PERSONS DIAGNOSED WITH CANCER. GENETIC COUNSELING EDUCATIONAL SESSIONS ARE OFFERED ON A REGULAR BASIS AT KCI AND BY APPOINTMENT. PARTICIPANTS LEARN ABOUT INHERITED BREAST AND OVARIAN CANCER GENES AND HOW TO REDUCE THEIR RISK. KCI ALSO SUPPORTS EFFORTS AND PROVIDES RESOURCES TO HELP INDIVIDUALS SUCCESSFULLY QUIT SMOKING. THE J.P. MCCARTHY CORD STEM CELL BANK AT KCI IS A PUBLIC, NON-PROFIT STEM CELL BANK WITH OVER 2,800 UMBILICAL CORD BLOOD UNITS IN ITS INVENTORY. THE BANK WAS FOUNDED IN 2001 WITH FUNDING FROM THE J.P. MCCARTHY FUND AND THE CARLS FOUNDATION AND IS ONE OF ONLY A FEW INTERNATIONALLY RECOGNIZED CORD STEM CELL BANKS AFFILIATED WITH THE NATIONAL MARROW DONOR PROGRAM. THE BANK WAS CREATED IN ANTICIPATION OF PROVIDING LIFE-SAVING HOPE TO PEOPLE WHO HAVE BEEN DIAGNOSED WITH CANCER AND SERIOUS BLOOD DISORDERS. KCI COLLECTED, PROCESSED AND STORES DONATED UMBILICAL CORD BLOOD THAT BECOMES A READILY AVAILABLE SOURCE OF HEMATOPOIETIC STEM CELLS FOR TRANSPLANT IN CHILDREN AND ADULTS WITH LEUKEMIA, LYMPHOMA, SICKLE CELL DISEASE OR OTHER LIFE-THREATENING CONDITIONS. THE J.P. MCCARTHY CORD BLOOD BANK AND CARLS PROCESSING LABORATORY IS ALSO ACCREDITED BY THE FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY (FACT). THE ACCREDITATION SIGNIFIES THE HIGHEST STANDARDS OF PRACTICE IN COLLECTION, PROCESSING AND TRANSPLANTATION. THIS ACCREDITATION DEMONSTRATES THE COMMITMENT TO QUALITY IN CORD BLOOD BANKING THROUGH ADHERENCE TO RIGOROUS STANDARDS THAT ARE VERIFIED BY PERIODIC INSPECTION AND PEER REVIEW.Expenses $5,124,314 · grants $87,906 · revenue $4,674,459
- KCI IS PART OF THE MICHIGAN BREAST & CERVICAL CONTROL PROGRAM (BCCCP): THIS PROGRAM IS AVAILABLE TO INDIVIDUALS MEETING THE FOLLOWING CRITERIA: (1) BE A MICHIGAN RESIDENT (OR RESIDE IN A STATE THAT BORDERS MICHIGAN) (2) HAVE AN INCOME BELOW 250% OF THE FEDERAL POVERTY LEVEL OR BELOW, (3) BE UNINSURED OR UNDERINSURED, (4) BE AGE 40-64 FOR BREAST CANCER SCREENING SERVICES AND DIAGNOSTIC SERVICES, (5) BE AGE 21-64 FOR CERVICAL CANCER SCREENING SERVICES AND DIAGNOSTIC SERVICES, (6) BE AGE 18-39 WITH A BREAST PROBLEM THAT REQUIRES DIAGNOSTIC SERVICES. THE BCCCP PROVIDES BREAST CARE SERVICES SUCH AS CLINICAL BREAST EXAMS (CBES), MAMMOGRAMS, AND FOLLOW UP TESTS. WHILE THE PROGRAM DOES NOT PROVIDE TREATMENT FOR BREAST CANCER, IT DOES ASSIST WITH APPLYING FOR THE MEDICAID TREATMENT ACT (MTA) WHICH DOES COVER CANCER TREATMENT FOR THOSE INDIVIDUALS DIAGNOSED THRU THE BCCCP. THE BCCCP PROVIDES CERVICAL RELATED CARE INCLUDING PELVIC EXAMS, PAP SMEARS, HPV TESTING AND FOLLOW-UP SERVICES IF NEEDED. WHILE THE PROGRAM DOES NOT PROVIDE TREATMENT FOR CERVICAL CANCER, IT DOES ASSIST WITH APPLYING FOR THE MEDICAID TREATMENT ACT (MTA) WHICH DOES COVER CANCER TREATMENT FOR THOSE INDIVIDUALS DIAGNOSED THRU THE BCCCP. THE BCCCP CAN ENROLL AND PROVIDE DIAGNOSTIC BREAST AND/OR DIAGNOSTIC CERVICAL SERVICES TO INSURED INDIVIDUALS WITH DEDUCTIBLE AMOUNTS THAT CREATE FINANCIAL HARDSHIP-IF THEY MEET THE ELIGIBILITY CRITERIA.Expenses $192,615 · revenue $192,615
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in September, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | September 30, 2026 | February 16, 2027 | Not due yet |
| 2024 | September 30, 2025 | February 17, 2026 | 990 on file |
| 2023 | September 30, 2024 | February 18, 2025 | 990 on file |
IRS record
- EIN
- 38-1613280
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1949
- Accounting year ends
- September
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H30)
- Assets (IRS master file)
- $295,118,020
- Income (IRS master file)
- $153,587,723
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | September 2025 | $27,111,385 | $33,992,462 | $295,118,020 | XML |
| 990 | September 2024 | $25,395,959 | $32,770,709 | $250,659,734 | XML |
| 990 | September 2023 | $24,422,883 | $32,095,526 | $262,170,775 | XML |
| 990 | September 2022 | $20,019,808 | $26,764,007 | $178,664,005 | IRS |
| 990 | September 2021 | – | – | – | IRS |
| 990 | September 2020 | – | – | – | IRS |
| 990 | September 2019 | – | – | – | IRS |
| 990 | September 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 38-1613280).
Questions about BARBARA ANN KARMANOS CANCER INSTITUTE
- What is the EIN of BARBARA ANN KARMANOS CANCER INSTITUTE?
- The employer identification number (EIN) of BARBARA ANN KARMANOS CANCER INSTITUTE is 38-1613280.
- Is BARBARA ANN KARMANOS CANCER INSTITUTE tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1949.
- Are donations to BARBARA ANN KARMANOS CANCER INSTITUTE tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does BARBARA ANN KARMANOS CANCER INSTITUTE file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of BARBARA ANN KARMANOS CANCER INSTITUTE due?
- The return for tax year 2025 (the year ending September 30, 2026) is due February 16, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did BARBARA ANN KARMANOS CANCER INSTITUTE last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended September 2025.
- Who is the principal officer of BARBARA ANN KARMANOS CANCER INSTITUTE?
- The 990 for the year ended September 30, 2025 names BORIS PASCHE MD.
- Who are the officers and directors of BARBARA ANN KARMANOS CANCER INSTITUTE?
- The 990 for the year ended September 30, 2025 lists 33 people; 18 received compensation from the organization.
- How much revenue does BARBARA ANN KARMANOS CANCER INSTITUTE have?
- On its 990 for the year ended September 30, 2025 it reported revenue of $27,111,385, expenses of $33,992,462 and total assets of $295,118,020 at year end.
Other nonprofits in DETROIT
- NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE EIN 99-3110088 · last filed 990-EZ for 2024
- KIDS WITHOUT CANCER EIN 38-2377242 · last filed 990 for 2025
- AFFILIATED UNIVERSITY NEPHROLOGISTS EIN 38-3544878 · last filed 990 for 2025
- EICOSANOID RESEARCH FOUNDATION EIN 27-0097769 · last filed 990-N for 2024
- HFII CORPORATION EIN 90-0840304 · last filed 990 for 2024
- ALIM HERBARIUM RESEARCH CENTER EIN 80-0188392 · last filed 990-N for 2025
- UPG SERVICES EIN 20-2486712 · last filed 990-N for 2023
- FOUNDATION FOR OPTHALMALIC RESEARCH AND EDUCATION EIN 38-3562965 · last filed 990-EZ for 2024